PACB vs UNP · rev $76.2M vs P/E 21, rev $6.86B
Pacific Biosciences of California (PACB) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
PACB currently screens at market cap $387.1M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the PACB and UNP stock pages for the full models.
Not investment advice.